Beat Childhood Cancer

Bringing hope to kids battling childhood cancers, through innovative clinical trials & research for #EveryChildEveryWhere

[Beat Childhood Cancer @beatccorg]

2025 was a year of progress, purpose, and heart. 💛

In 2025, our community turned hope into action.

Thank you for being the heartbeat of this movement. Together, we’re not just beating childhood cancer, we are rewriting what IS possible.

#BeatChildhoodCancer

[Beat Childhood Cancer @beatccorg]

52/52.
Every Tuesday answered. Every action counted.

Today marks the final Take Action Tuesday of 2025.

2025 may be closing! But the mission continues. Light the Fight and find all the ways you can take action with Beat Childhood Cancer at https://t.co/o3FYm8Rfkw

[Beat Childhood Cancer @beatccorg]

Dr. Francis Eshun and the team at Site 17- Phoenix Children's, Phoenix, AZ are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

[Beat Childhood Cancer @beatccorg]

Dr. Jessica Sun and the team at Site 50- Duke Children’s, Durham, NC are officially approved to enroll on BCC022– Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma.

#BeatChildhoodCancer #ChildhoodCancerResearch

[Beat Childhood Cancer @beatccorg]

From our Beat Childhood Cancer family to yours, we’re wishing you a season filled with warmth, hope, and health. Thank you for helping us bring light to families facing the unimaginable. Merry Christmas and Happy Holidays!

May all your days be merry and bright.

[Beat Childhood Cancer @beatccorg]

Dr. Michael Isakoff and the team at Site 09 – Connecticut Children's Medical Center, Hartford, CT are officially approved to enroll on BCC020– A Dose Escalation Study Using Eflornithine (DFMO) and AMXT 1501.

[Beat Childhood Cancer @beatccorg]

Today marks 51/52 of Take Action Tuesday, and this second-to-last Take Action Tuesday of the year is all about getting active.
Introducing Run 26 in ’26!

We’re looking for 26 people to commit to 26.2 miles in 2026 in support of Beat Childhood Cancer: https://t.co/EyufoCgT6C

[Beat Childhood Cancer @beatccorg]

Dr. Monia Marzouki and the team at Site 84- CHU Sainte Justine, Montreal, QC, Canada are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

[Beat Childhood Cancer @beatccorg]

Dr. Daniel Benedetti and the team at Vanderbilt-Ingram Cancer Center in Nashville, TN are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

[Beat Childhood Cancer @beatccorg]

Lace up, tee off, dress up, spread out a picnic blanket, grab your change, celebrate, remember and choose hope.

Explore the growing lineup of 2026 events supporting the Beat Childhood Cancer Foundation and save the dates at https://t.co/oALiVBTT1f

#BeatChildhoodCancer

[Beat Childhood Cancer @beatccorg]

Dr. Jennifer Dean and her team at Site 24 - All Children's in St Petersburg, FL are now officially approved to enroll on BCC016– Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.

[Beat Childhood Cancer @beatccorg]

Dr. William Roberts and his team at Site 03 - Rady Children’s in San Diego, CA are officially approved to enroll on BCC021– Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors.

[Beat Childhood Cancer @beatccorg]

Dr. Kevin Bielamowicz and his team at Site 29 - Arkansas Children’s, in Little Rock, AR are officially approved to enroll on BCC020.

[Beat Childhood Cancer @beatccorg]

21 days left to Light the Fight.

Today, we’re turning our focus to the fighters who made it through.

This is for our childhood cancer survivors ... their strength, their resilience, and the road they’ve traveled.

🔗 https://t.co/i2TMd2yFYC

#BeatChildhoodCancer #LighttheFight

[Beat Childhood Cancer @beatccorg]

Today is Week 49/52 of Take Action Tuesday which means there are just 4 Tuesdays left in 2025 to make your impact!

Our BeatCC merch shop is stocked with new holiday items.

Shop with purpose today: https://t.co/0EoqHWbKjd
Because taking action can be as simple as what you wear.

[Beat Childhood Cancer @beatccorg]

Dr. Kelley Hutchins and her team at Site 14 - Kapiolani Medical Center for Women and Children in Honolulu, HI are officially approved to enroll on BCC022– Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma.

#BeatChildhoodCancer #Neuroblastoma

[Beat Childhood Cancer @beatccorg]

Our map is starting to glow! Ten states lit up with generosity, hope, and heart.

And together, we can make it shine even brighter.

Let’s light this map, coast to coast!
To give: https://t.co/i2TMd2yFYC

#BeatChildhoodCancer #LighttheFight #ChildhoodCancerResearch

[Beat Childhood Cancer @beatccorg]

Join us for The Biggest Picnic, our newest signature event for the whole family!

On Sunday, February 22nd, we’re bringing the greater Tampa/St. Pete communities together at Elva Rouse Park in St. Petersburg.

Grab your tickets: https://t.co/9n1IoZWdOy

#BeatChildhoodCancer

[Beat Childhood Cancer @beatccorg]

“Mindfulness isn’t just listening to yourself, it’s talking to yourself.”

Thank you to everyone who joined us for our first-ever webinar, Mantras of Hope with Case Kenny.

If you created a mantra with us last night, don't forget to tag us when you share it on social media.

[Beat Childhood Cancer @beatccorg]

Today marks Week 48/52 of #TakeActionTuesday and what better time than right now to make your impact?

There’s still time to sign up for Mantras of Hope, our free one-hour virtual experience happening tonight at 7pm EST.

➡️ Register for free!
https://t.co/p0uzoN5OaH